The 3rd Consortium Meeting was full of interesting updates and point of views that enriched the project and drove us for the next part of the journey. Thanks to the nearly 150 attendees for their contributions. We’re on the right track! #imi_era4tb #tuberculosis @AMRAccelerator
A day full of scientific interaction, learning from each other (especially between experimentalists and modellers). @EUFEPS conference in the morning, @IMI_ERA4TB consortium meeting in the afternoon! 🤓 https://twitter.com/IMI_ERA4TB/status/1402546599474221056
We’ve been working very hard the last few months and it’s time to get together to share the project updates. We're all ready for the third Consortium Meeting! #imi #era4tb #tuberculosis @AMRAccelerator
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.